BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 20373248)

  • 1. SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International Conference.
    Skaug B; Chen ZJ
    IDrugs; 2010 Apr; 13(4):224-7. PubMed ID: 20373248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site.
    Paiva SL; da Silva SR; de Araujo ED; Gunning PT
    J Med Chem; 2018 Jan; 61(2):405-421. PubMed ID: 28076680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEDD8 overexpression results in neddylation of ubiquitin substrates by the ubiquitin pathway.
    Hjerpe R; Thomas Y; Kurz T
    J Mol Biol; 2012 Aug; 421(1):27-9. PubMed ID: 22608973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into functional modes of proteins involved in ubiquitin family pathways.
    Hänzelmann P; Schäfer A; Völler D; Schindelin H
    Methods Mol Biol; 2012; 832():547-76. PubMed ID: 22350912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.
    Kumar R; González-Prieto R; Xiao Z; Verlaan-de Vries M; Vertegaal ACO
    Nat Commun; 2017 Nov; 8(1):1809. PubMed ID: 29180619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunction of the ubiquitin proteasome and ubiquitin-like systems in schizophrenia.
    Rubio MD; Wood K; Haroutunian V; Meador-Woodruff JH
    Neuropsychopharmacology; 2013 Sep; 38(10):1910-20. PubMed ID: 23571678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-like Protein Conjugation: Structures, Chemistry, and Mechanism.
    Cappadocia L; Lima CD
    Chem Rev; 2018 Feb; 118(3):889-918. PubMed ID: 28234446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting SUMO Signaling to Wrestle Cancer.
    Kroonen JS; Vertegaal ACO
    Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response.
    Poulsen SL; Hansen RK; Wagner SA; van Cuijk L; van Belle GJ; Streicher W; Wikström M; Choudhary C; Houtsmuller AB; Marteijn JA; Bekker-Jensen S; Mailand N
    J Cell Biol; 2013 Jun; 201(6):797-807. PubMed ID: 23751493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific substrate recognition and thioester intermediate determinations in ubiquitin and SUMO conjugation cascades revealed by a high-sensitive FRET assay.
    Jiang L; Saavedra AN; Way G; Alanis J; Kung R; Li J; Xiang W; Liao J
    Mol Biosyst; 2014 Apr; 10(4):778-86. PubMed ID: 24452848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
    Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
    Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
    Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
    PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SUMO chains: polymeric signals.
    Vertegaal AC
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):46-9. PubMed ID: 20074033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMO and ubiquitin paths converge.
    Denuc A; Marfany G
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):34-9. PubMed ID: 20074031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to Trap Enzyme-Substrate Complexes that Mimic Michaelis Intermediates During E3-Mediated Ubiquitin-Like Protein Ligation.
    Streich FC; Lima CD
    Methods Mol Biol; 2018; 1844():169-196. PubMed ID: 30242710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
    Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
    J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
    Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
    Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.